BRAINAURORA-B (06681) signs a strategic cooperation agreement with Lake Boss to expand the Singapore market and promote international layout.

BRAINAURORA-B (06681) announces that the company has recently signed a strategic cooperation agreement with Natural Health Solutions Programme Group Holdings (Natural Health Solutions) in Singapore. Both parties will collaborate in promoting products and expanding markets in the Singapore market to promote the development of the digital health industry. Singapore is one of the developed economies in Asia and is facing the challenge of rapid population aging. According to Singapore government data, the proportion of people aged 65 and above is rising, and the prevalence of cognitive impairment (dementia) is also significant. The Singapore government actively promotes national projects such as the "Health SG" program and the "Dementia-Friendly Singapore", encouraging early screening and holistic health management, providing a good policy environment and market foundation for cognitive impairment digital therapy products. As a pioneer in the Chinese cognitive impairment digital therapy market, the company's core product, the "Brain Function Information Management Platform Software System," is the first cognitive impairment digital therapy product in China to be approved by regulators and has been included in the medical insurance reimbursement catalog in 30 provinces in China. Natural Health Solutions is a professional health management services organization headquartered in Singapore and has independently developed the SC Health AI digital health assessment system, with service networks covering community medical and health management markets. Under the agreement, the cooperation between the two parties mainly includes the following: (I) Product promotion cooperation: The company is responsible for local adaptation, system implementation, and personnel training support of cognitive impairment digital therapy products in Singapore; Natural Health Solutions will rely on its offline stores and member resources to recommend the company's products to target users and provide full-service processes, including product introduction, trial guidance, purchase conversion, and after-sales support. (II) Collaborative market expansion: Both parties will integrate resources such as products, channels, brands, and technologies to jointly expand the Singapore market, focusing on promoting the company's products to enter the top private hospitals and public hospital systems in Singapore to enhance the application and popularity of the products in the local medical system. The Board believes that this cooperation will bring long-term development opportunities for the company and create sustainable value for shareholders. Specifically, it will: (I) Deepen international layout and expand overseas markets: The company has started product promotion and operations in Hong Kong and Macau, China, and has initially accumulated overseas market experience. The cooperation with Natural Health Solutions marks the official launch of the company's market layout and business expansion in Southeast Asia. This will help systematically export the digital therapy experience and technical system accumulated in the Chinese market to other regions with scale and policy support, further expanding the company's international brand influence and business coverage, enhancing global influence. (II) Strengthen brand influence and business network: This collaboration further strengthens the company's brand authority and professional image in the field of digital healthcare. With the help of Natural Health Solutions' health management network in Singapore, the company can accelerate the landing of products in local medical institutions, shorten the market introduction cycle, and expand into diverse markets such as digital health management.